Unknown

Dataset Information

0

Inhibition of Interleukin-6/glycoprotein 130 signalling by Bazedoxifene ameliorates cardiac remodelling in pressure overload mice.


ABSTRACT: The role of IL-6 signalling in hypertensive heart disease and its sequelae is controversial. Our group demonstrated that Bazedoxifene suppressed IL-6/gp130 signalling in cancer cells but its effect on myocardial pathology induced by pressure overload is still unknown. We explored whether Bazedoxifene could confer benefits in wild-type C57BL/6J mice suffering from transverse aortic constriction (TAC) and the potential mechanisms in H9c2 myoblasts. Mice were randomized into three groups (Sham, TAC, TAC+Bazedoxifene, n = 10). Morphological and histological observations suggested TAC aggravated myocardial remodelling while long-term intake of Bazedoxifene (5 mg/kg, intragastric) attenuated pressure overload-induced pathology. Echocardiographic results indicated Bazedoxifene rescued cardiac function in part. We found Bazedoxifene decreased the mRNA expression of IL-6, MMP2, Col1A1, Col3A1 and periostin in murine hearts after 8-week surgery. By Western blot detection, we found Bazedoxifene exhibited an inhibition of STAT3 activation in mice three hours and 8 weeks after TAC. Acute TAC stress (3 hours) led to down-regulated ratio of LC3-?/LC3-?, while in mice after long-term (8 weeks) TAC this ratio becomes higher than that in Sham mice. Bazedoxifene inverted the autophagic alteration induced by TAC at both two time-points. In H9c2 myoblasts, Bazedoxifene suppressed the IL-6-induced STAT3 activation. Moreover, IL-6 reduced the ratio of LC3-?/LC3-?, promoted P62 expression but Bazedoxifene reversed both changes in H9c2 cells. Our data suggested Bazedoxifene inhibited IL-6/gp130 signalling and protected against cardiac remodelling together with function deterioration in TAC mice.

SUBMITTER: Shi W 

PROVIDER: S-EPMC7176848 | biostudies-literature | 2020 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

Inhibition of Interleukin-6/glycoprotein 130 signalling by Bazedoxifene ameliorates cardiac remodelling in pressure overload mice.

Shi Wei W   Ma Haiyan H   Liu Tianshu T   Yan Dan D   Luo Pengcheng P   Zhai Maocai M   Tao Jingwen J   Huo Shengqi S   Guo Junyi J   Li Chenglong C   Lin Jiayuh J   Zhang Cuntai C   Li Sheng S   Lv Jiagao J   Lin Li L  

Journal of cellular and molecular medicine 20200312 8


The role of IL-6 signalling in hypertensive heart disease and its sequelae is controversial. Our group demonstrated that Bazedoxifene suppressed IL-6/gp130 signalling in cancer cells but its effect on myocardial pathology induced by pressure overload is still unknown. We explored whether Bazedoxifene could confer benefits in wild-type C57BL/6J mice suffering from transverse aortic constriction (TAC) and the potential mechanisms in H9c2 myoblasts. Mice were randomized into three groups (Sham, TAC  ...[more]

Similar Datasets

| S-EPMC6279202 | biostudies-literature
| S-EPMC8006657 | biostudies-literature
| S-EPMC8353202 | biostudies-literature
2010-01-19 | E-GEOD-18224 | biostudies-arrayexpress
2005-06-29 | GSE2459 | GEO
| S-EPMC6398888 | biostudies-other
| S-EPMC3294280 | biostudies-literature
2010-01-20 | GSE18224 | GEO
| S-EPMC7180191 | biostudies-literature
2002-07-30 | GSE76 | GEO